1. Home
  2. EVLV vs LRMR Comparison

EVLV vs LRMR Comparison

Compare EVLV & LRMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVLV
  • LRMR
  • Stock Information
  • Founded
  • EVLV 2013
  • LRMR N/A
  • Country
  • EVLV United States
  • LRMR United States
  • Employees
  • EVLV N/A
  • LRMR N/A
  • Industry
  • EVLV Computer peripheral equipment
  • LRMR Biotechnology: Pharmaceutical Preparations
  • Sector
  • EVLV Technology
  • LRMR Health Care
  • Exchange
  • EVLV Nasdaq
  • LRMR Nasdaq
  • Market Cap
  • EVLV 392.3M
  • LRMR 426.9M
  • IPO Year
  • EVLV N/A
  • LRMR N/A
  • Fundamental
  • Price
  • EVLV $2.88
  • LRMR $6.18
  • Analyst Decision
  • EVLV Strong Buy
  • LRMR Strong Buy
  • Analyst Count
  • EVLV 5
  • LRMR 8
  • Target Price
  • EVLV $5.60
  • LRMR $19.63
  • AVG Volume (30 Days)
  • EVLV 4.2M
  • LRMR 744.4K
  • Earning Date
  • EVLV 11-26-2024
  • LRMR 10-30-2024
  • Dividend Yield
  • EVLV N/A
  • LRMR N/A
  • EPS Growth
  • EVLV N/A
  • LRMR N/A
  • EPS
  • EVLV N/A
  • LRMR N/A
  • Revenue
  • EVLV $89,220,000.00
  • LRMR N/A
  • Revenue This Year
  • EVLV $28.84
  • LRMR N/A
  • Revenue Next Year
  • EVLV $30.41
  • LRMR N/A
  • P/E Ratio
  • EVLV N/A
  • LRMR N/A
  • Revenue Growth
  • EVLV 17.67
  • LRMR N/A
  • 52 Week Low
  • EVLV $2.01
  • LRMR $3.09
  • 52 Week High
  • EVLV $5.73
  • LRMR $13.68
  • Technical
  • Relative Strength Index (RSI)
  • EVLV 48.93
  • LRMR 34.63
  • Support Level
  • EVLV $2.53
  • LRMR $5.92
  • Resistance Level
  • EVLV $2.76
  • LRMR $6.60
  • Average True Range (ATR)
  • EVLV 0.18
  • LRMR 0.69
  • MACD
  • EVLV 0.08
  • LRMR -0.32
  • Stochastic Oscillator
  • EVLV 98.00
  • LRMR 4.45

About EVLV Evolv Technologies Holdings Inc.

Evolv Technologies Holdings Inc offers an AI-based touchless security screening. Its touchless security screening systems use artificial intelligence software, cloud services, and advanced sensors to reliably detect dangerous weapons while ignoring harmless items like cell phones, laptops, and keys. It offers products for purchase and primarily under a multi-year security-as-a-service subscription pricing model that delivers ongoing value to customers, generates predictable revenue, and creates expansion and upsell opportunities. The firm operates in a single segment that develops, manufactures, markets, and sells security screening products and specific services. Its products are used in different industries such as casinos, industrial workplaces, schools, and ticketed venues.

About LRMR Larimar Therapeutics Inc.

Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using novel cell-penetrating peptide technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.

Share on Social Networks: